share_log

HC Wainwright & Co. Maintains Buy on X4 Pharmaceuticals, Raises Price Target to $5

HC Wainwright & Co. Maintains Buy on X4 Pharmaceuticals, Raises Price Target to $5

HC Wainwright & Co.维持对X4制药的买入,将目标股价上调至5美元
Benzinga ·  04/30 06:52

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains X4 Pharmaceuticals (NASDAQ:XFOR) with a Buy and raises the price target from $3 to $5.

HC Wainwright & Co. 分析师Swayampakula Ramakanth维持X4制药公司(纳斯达克股票代码:XFOR)的买入并将目标股价从3美元上调至5美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发